(Q44361154)

2 December 2017

title

Modified method to measure nasal potential difference (English)

1 reference

2 December 2017

1

Teresinha Leal

1 reference

2 December 2017

Jean Lebacq

2

1 reference

2 December 2017

Patrick Lebecque

series ordinal

3

1 reference

2 December 2017

Jean Cumps

series ordinal

4

1 reference

2 December 2017

Pierre Wallemacq

series ordinal

5

1 reference

2 December 2017

publication date

1 January 2003

1 reference

Clinical Chemistry and Laboratory Medicine

2 December 2017

published in

1 reference

2 December 2017

volume

41

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

61-67

1 reference

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

Transepithelial potential difference in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

A new device for in vivo measurement of nasal transepithelial potential difference in cystic fibrosis patients and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

A modified technique for measurement of nasal transepithelial potential difference in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

Nasal potential difference measurements in patients with atypical cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

Characterization of mutations located in exon 18 of the CFTR gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.011

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.011

1 reference

2 December 2017

1 reference